摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-[(3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethyl-3-oxospiro[2,4,4a,5,6,6a,6b,7,8,10,12,12a-dodecahydro-1H-naphtho[2,1-a]azulene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-2-(2H-tetrazol-5-yl)acetamide | 1037210-20-0

中文名称
——
中文别名
——
英文名称
N-[2-[(3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethyl-3-oxospiro[2,4,4a,5,6,6a,6b,7,8,10,12,12a-dodecahydro-1H-naphtho[2,1-a]azulene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-2-(2H-tetrazol-5-yl)acetamide
英文别名
——
N-[2-[(3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethyl-3-oxospiro[2,4,4a,5,6,6a,6b,7,8,10,12,12a-dodecahydro-1H-naphtho[2,1-a]azulene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-2-(2H-tetrazol-5-yl)acetamide化学式
CAS
1037210-20-0
化学式
C33H50N6O3
mdl
——
分子量
578.798
InChiKey
RZLUFYMRZZYREW-SSPCIXLPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    42
  • 可旋转键数:
    5
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    113
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • Transfer Hydrogenation of Cyclopamine Analogs
    申请人:Genov Daniel G.
    公开号:US20120065399A1
    公开(公告)日:2012-03-15
    Provided herein is a process for the transfer-hydrogenation of ketone analogs of members of the jervine type of Veratrum alkaloids, such as cyclopamine. Also provided herein are novel ruthenium transfer-hydrogenation catalysts.
    本文提供了一种用于将似jervine型Veratrum生物碱的酮类似物(如环毒素)进行转移氢化的方法。本文还提供了新型的钌转移氢化催化剂。
  • [EN] TRANSFER HYDROGENATION OF CYCLOPAMINE ANALOGS<br/>[FR] HYDROGÉNATION PAR TRANSFERT D'ANALOGUES DE CYCLOPAMINE
    申请人:INFINITY PHARMACEUTICALS INC
    公开号:WO2012037217A1
    公开(公告)日:2012-03-22
    Provided herein is a process for the transfer-hydrogenation of ketone analogs of members of the jervine type of Veratrum alkaloids, such as cyclopamine. Also provided herein are novel ruthenium transfer-hydrogenation catalysts.
    本文提供了一种用于转移氢化物的过程,适用于jervine型Veratrum生物碱的酮类似物,如环状毒草碱。本文还提供了新颖的铑转移氢化催化剂。
  • TRANSFER HYDROGENATION OF CYCLOPAMINE ANALOGS
    申请人:Infinity Pharmaceuticals, Inc.
    公开号:US20170029433A1
    公开(公告)日:2017-02-02
    Provided herein is a process for the transfer-hydrogenation of ketone analogs of members of the jervine type of Veratrum alkaloids, such as cyclopamine. Also provided herein are novel ruthenium transfer-hydrogenation catalysts.
    本文提供了一种将拟麻酮类似物,如环状毒草碱转移氢化的方法,例如环状毒草碱。本文还提供了新型的钌催化剂用于转移氢化反应。
  • Methods of use for cyclopamine analogs
    申请人:Infinity Discovery, Inc.
    公开号:EP2368551A2
    公开(公告)日:2011-09-28
    The invention provides methods for treating various conditions using derivatives of cyclopamine having the following formula:
    本发明提供了使用具有下式的环丙胺衍生物治疗各种疾病的方法:
  • Cyclopamine analogs
    申请人:Infinity Discovery, Inc.
    公开号:EP2443926A2
    公开(公告)日:2012-04-25
    The invention provides novel derivatives of cyclopamine having the following formula: wherein the nature of the moieties R1, R2, R3, R4, R7, R7', R8 and R9 is defined in appended claim 1.
    本发明提供了具有下式的环丙胺新型衍生物: 其中分子 R1、R2、R3、R4、R7、R7'、R8 和 R9 的性质在所附权利要求 1 中定义。
查看更多